What medication is used for lower gastrointestinal (GI) bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Medications for Lower Gastrointestinal (GI) Bleeding For the management of lower gastrointestinal bleeding, medications such as tranexamic acid may be considered at a dose of 1-1.5 grams orally every 8 hours for 3-5 days to promote hemostasis 1. Additionally, proton pump inhibitors (PPIs) like pantoprazole or esomeprazole may be administered at a dose of 40-80 mg intravenously every 24 hours for 3-5 days to reduce gastric acid secretion, although their use is more commonly associated with upper GI bleeding 1.

  • Key considerations for medication use in lower GI bleeding include:
    • The use of tranexamic acid to promote hemostasis in cases of bleeding due to angiodysplasia or diverticulosis 1
    • The administration of PPIs to reduce gastric acid secretion, particularly in patients at increased risk of GI bleeding 1
    • The potential interactions between PPIs and other medications, such as clopidogrel, and the need to carefully consider these interactions when selecting medications for patients with lower GI bleeding 1

From the Research

Medication for Lower Gastrointestinal (GI) Bleeding

There are several medications and treatments that can be used to manage lower gastrointestinal bleeding, including:

  • Octreotide, a synthetic analogue of somatostatin, which can reduce splanchnic blood flow and has been used to treat variceal bleeding 2
  • Vasopressin infusion, which can be used to treat LGIB, although it is not as commonly used as other treatments 3
  • Embolization, which can be used to control bleeding in cases where endoscopy or other treatments are not effective 3, 4

Treatment Approaches

The choice of treatment for LGIB depends on the severity of the bleeding, the patient's hemodynamic status, and the availability of resources. Treatment approaches may include:

  • Colonoscopy, which is the diagnostic and therapeutic procedure of choice for acute and chronic bleeding 5, 6, 4
  • Angiography, which can be used to diagnose and treat bleeding, particularly in cases where colonoscopy is not possible or has failed 6, 3, 4
  • Surgery, which may be necessary in severe cases of bleeding where other treatments have failed 6, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Octreotide, a new somatostatin analogue.

Clinical pharmacy, 1989

Research

Management of Acute Lower Gastrointestinal Bleeding.

Techniques in vascular and interventional radiology, 2017

Research

The management of lower gastrointestinal bleeding.

Journal of visceral surgery, 2014

Research

Diagnosis and management of lower gastrointestinal bleeding.

Nature reviews. Gastroenterology & hepatology, 2009

Related Questions

What is the most appropriate next step in management for a patient with lower GI bleeding who remains unstable despite resuscitation with fluids and blood?
What are the causes of massive lower gastrointestinal bleeding (LGIB)?
What is the most appropriate initial management for an unstable patient with lower gastrointestinal bleeding, hypotension, and evidence of ongoing bleeding?
What is the next step in managing a patient with lower gastrointestinal (GI) bleeding and hypotension despite initial resuscitation efforts?
How are lower gastrointestinal (GI) bleedings classified?
What are the risks and contraindications of administering multiple antipsychotics, including Latuda (lurasidone), Zyprexa (olanzapine), Haldol (haloperidol), and Thorazine (chlorpromazine), to an adult patient with a genetically confirmed resistance to psychosis, suspected Attention Deficit Hyperactivity Disorder (ADHD), and intersex condition, who has reported sexual abuse and harassment by staff, and is being denied their right to fill out an Advanced Directive/Power of Attorney (PoA)?
What are the risks and contraindications of administering multiple antipsychotics, including Latuda (lurasidone), Zyprexa (olanzapine), Haldol (haloperidol), and Thorazine (chlorpromazine), to an adult patient with a genetically confirmed resistance to psychosis, suspected Attention Deficit Hyperactivity Disorder (ADHD), and intersex condition, who has reported sexual abuse and harassment by staff, and is being denied their right to fill out an Advanced Directive/Power of Attorney (PoA)?
Is a 2.3 x 0.9 x 1.6 cm hypoechoic structure in the left lateral uterine wall suggestive of a uterine fibroid (Leiomyoma) and an indication for Cesarean Section (CS)?
What is the principle behind combining corticosteroids (steroids) with other medications in ophthalmic eye drops, rather than using corticosteroids alone?
Can Tamiflu (Oseltamivir) be given rectally?
What are the effects of combining Magnesium, Vitamin D3 (Cholecalciferol), and Vitamin K2 (Menatetrenone)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.